Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
Berberine has lipid-lowering effects and other metabolic benefits, but it presents with poor bioavailability. Here the authors conjugate berberine to liver-targeting nanoparticles, and show increased accumulation of berberine in the liver, improved metabolic profiles and reduced atherosclerotic plaq...
Enregistré dans:
Auteurs principaux: | Hui-Hui Guo, Chen-Lin Feng, Wen-Xuan Zhang, Zhi-Gang Luo, Hong-Juan Zhang, Ting-Ting Zhang, Chen Ma, Yun Zhan, Rui Li, Song Wu, Zeper Abliz, Cong Li, Xiao-Lin Li, Xiao-Lei Ma, Lu-Lu Wang, Wen-Sheng Zheng, Yan-Xing Han, Jian-Dong Jiang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f1dbe28cac9f4edfac9a5a63a81b496e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
par: Xue M, et autres
Publié: (2015) -
Atheroprotective Effects and Molecular Mechanism of Berberine
par: Lu Xing, et autres
Publié: (2021) -
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
par: Miao-Miao Zhao, et autres
Publié: (2021) -
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
par: Dkhi,Mohamed A
Publié: (2014) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
par: Peisen Zhang, et autres
Publié: (2021)